ASND Articles, Ascendis Pharma A/S

No one has written and article on Ascendis Pharma A/S, stock symbol ASND. Be the first to contribute and write an article.

Stock Information

Ascendis Pharma A/S Company Name:

ASND Stock Symbol:

NASDAQ Market:

Ascendis Pharma A/S Website:

Get ASND Alerts

News, Short Squeeze, Breakout and More Instantly...

ASND - Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon(TM) PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022

– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism on Tuesday, June 14 – Oral presentation of TransCon PTH Phase 2 PaTH Forward Trial Open-Label Extension Data in adult hypoparathyroidism on ...
ASND - Ascendis Pharma A/S Announces New Commercial Endocrinology Leadership Appointments

- Joe Kelly has been appointed to the newly created role of Head of U.S. Commercial, Endocrinology - Scott A. Holmes has been appointed to the newly created role of Head of Global Commercial Strategy, Endocrinology - Jesper Høiland, Global Chief Comm...
ASND - Positive Results from VISEN's Phase 3 Trial of Once-Weekly TransCon hGH in China Consistent with Ascendis Pharma's Phase 3 Height Trial

- VISEN’s Phase 3 Trial achieved primary endpoint; pediatric growth hormone deficiency (GHD) patients treated with TransCon™ hGH demonstrated greater annualized height velocity at 52-weeks (p=0.0010) compared to patients treated with daily growth hormone ...